logo

For the Inventor, By the Inventor

Acton, MA, United States of America

Insulet Corporation


USPTO Granted Patents = 190



Trademarks = 22

Forward Citations = 14,824

Loading Chart...
Loading Chart...

136 inventors (with patents filed for the assignee):

goldMedal David I Nazzaro (47 out of 75 patents)

silverMedal Ian T McLaughlin (44 out of 44 patents)

bronzeMedal Jason B O'Connor (40 out of 40 patents)

4.  Joon Bok Lee (37 out of 37 patents)

5.  Yibin Zheng (32 out of 40 patents)

6.  Daniel Allis (24 out of 24 patents)

7.  Steven P Cardinali (23 out of 51 patents)

8.  Maureen McCaffrey (22 out of 22 patents)

9.  J Christopher Flaherty (17 out of 267 patents)

10.  Sandhya Pillalamarri (17 out of 17 patents)

11.  Jorge Borges (17 out of 17 patents)

12.  Ashutosh Zade (16 out of 17 patents)

13.  Kevin Guido Schmid (14 out of 14 patents)

14.  Bryan Mazlish (12 out of 73 patents)

15.  Jason O'connor (12 out of 12 patents)


Core Competencies:
Insulin Delivery
Drug Delivery Device
Automated Insulin Delivery
Infusion Pump Systems
Fluid Delivery Device
Artificial Pancreas System
Glucose Monitoring
Adaptive Control Parameters
Medication Delivery
Wearable Medical Devices
Fuzzy Logic Control
Occlusion Resolution

190 patents:

1. 12496399 - Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk (2025-12-16),
2. 12496398 - Threshold based automatic glucose control response (2025-12-16),
3. 12495994 - Meal bolus subcategories in model based insulin therapy (2025-12-16),
4. 12491316 - Scheduling of medicament bolus deliveries by a medicament delivery device at future dates and times with a computing device (2025-12-09),
5. 12491310 - Wearable drug delivery device with removal element (2025-12-09),
6. 12485223 - Controlling insulin delivery (2025-12-02),
7. 12478738 - Methods and systems for sterilizing sealed components of a drug delivery device (2025-11-25),
8. 12458751 - Fluid delivery device having multiple penetrating elements (2025-11-04),
9. 12440617 - Linear activated drug dosing pump system (2025-10-14),
10. 12433998 - Activity mode for artificial pancreas system (2025-10-07),
11. 12433512 - Adhesive pad with a metallic coil for securing an on-body medical device (2025-10-07),
12. 12431229 - Medicament delivery device with an adjustable and piecewise analyte level cost component to address persistent positive analyte level excursions (2025-09-30),
13. 12429141 - Low force valves for drug delivery pumps (2025-09-30),
14. 12427251 - User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system (2025-09-30),
15. 12420022 - Drug delivery device with indicator (2025-09-23),
Insulet Corporation is an innovative medical device company that develops, manufactures, and sells insulin delivery systems for people with diabetes. Their flagship product, the Omnipod System, is a tubeless insulin pump designed for simplicity, flexibility, and convenience. With their dedication to improving the lives of individuals with diabetes, Insulet Corporation is transforming the way insulin is delivered, providing insulin-dependent people with a discreet and reliable method of insulin administration.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

...
190 Patents

#1 in Acton, MA

#121 in Massachusetts

#2,086 in US

#4,302 in the World

...
Acton, MA, United States of America

Insulet Corporation

Forward Citations = 14,824

136 inventors:

goldMedal David I Nazzaro (47 out of 75 patents)

silverMedal Ian T McLaughlin (44 out of 44 patents)

bronzeMedal Jason B O'Connor (40 out of 40 patents)

4.  Joon Bok Lee (37 out of 37 patents)

5.  Yibin Zheng (32 out of 40 patents)

Please report any incorrect information to support@idiyas.com
Loading…